Analysis

Lir Life Sciences Corp. (SKNY) Stock Analysis

Lir Life Sciences Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to SKNY.

websiteSKNY/analysis/SKNY

Lir Life Sciences Corp.

Lir Life Sciences Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to SKNY.

Stock profile

Ticker

SKNY

Asset type

Stock

Market cap

$6.9M

Sector

Non-Energy Minerals

Industry

Other Metals/Minerals

Currency

CAD

Ticker listings

Lir Life Sciences Corp. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • SKNY primary listing
  • N790
  • A41QA9
  • BBCMF

Latest Lir Life Sciences Corp. news

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and T...

VANCOUVER, BC / ACCESS Newswire / June 17, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTCPK:BBCMF)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company")is pleased to announce the...

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

VANCOUVER, BC / ACCESS Newswire / May 22, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTCPK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announce that ...

LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules

LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of...

VANCOUVER, BC / ACCESS Newswire / January 29, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company")is pleased to announc...

Research sections

Valuation

Review valuation context for Lir Life Sciences Corp..

Future growth

Review future growth context for Lir Life Sciences Corp..

Past performance

Review past performance context for Lir Life Sciences Corp..

Financial health

Review financial health context for Lir Life Sciences Corp..

Dividend

Review dividend context for Lir Life Sciences Corp..

Management

Review management context for Lir Life Sciences Corp..

Ownership

Review ownership context for Lir Life Sciences Corp..

Other information

Review other information context for Lir Life Sciences Corp..

Community

Review community context for Lir Life Sciences Corp..